The National Enquirer has learned that Mike Myers has been offered tens of millions of dollars to reprise the role of shagalicious British spy Austin Powers in a long-awaited fourth film, but he keeps ...
FOX 5 New York on MSN
Inside 50 Cent's Diddy documentary on Netflix: Beef, jurors, rappers, more allegations
Ddidy is set to be released in May 2028, though he can earn reductions in his time behind bars through his participation in ...
Acute coronary syndrome (ACS) is an umbrella term for situations in which the blood supplied to the heart muscle is suddenly reduced, usually due to a clot. ACS includes myocardial infarction (MI), ...
April Lampros called on Diddy to admit whether he underwent STD testing and disclosed results before the alleged assaults.
Nov 14 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab and Johnson & Johnson (JNJ.N), opens new tab have halted a major late-stage trial of their experimental blood clot drug, after an ...
The trial in the lawsuit filed by 23XI Racing and Front Row Motorsports against NASCAR is set to begin Dec. 1 and last 10 days. Haven’t been paying attention over the last 14 months since it has been ...
A new Netflix documentary will recount the rise and fall of the disgraced music mogul, Sean "Diddy" Combs, following his four-year-long prison sentence over his conviction on federal prostitution ...
The Los Angeles County Sheriff's Department is looking into a newly reported sexual battery allegation against Sean "Diddy" Combs. The Los Angeles Sheriff's Office received a report detailing the ...
The length of Sean "Diddy" Combs' prison stay has been amended. The rap mogul, who was sentenced to 50 months in prison in October after being found guilty of two counts of transportation to engage in ...
Sean “Diddy” Combs is under investigation for new sexual assault claims in Los Angeles. According to ABC News, the Los Angeles County Sheriff’s Department received a report about Diddy, 56, on Friday, ...
Shares of Bristol Myers Squibb (BMY) fell ~5% in the premarket on Friday after the company said that a Phase 3 trial for milvexian, an anticoagulant it is advancing with Johnson & Johnson (JNJ), is ...
Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals, a development that also helped a rival creating a competing drug. Bayer didn’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results